Cocaine Inhibits Dopamine D2 Receptor Signaling via Sigma-1-D2 Receptor Heteromers

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Navarro, Gemma ^a   Moreno, Estefania ^a   Bonaventura, Jordi ^a   Brugarolas, Marc ^a   Farré, Daniel ^a   Aguinaga, David ^a   Mallol, Josefa ^a   Cortés, Antoni ^a   Casadó, Vicent ^a   Lluís, Carmen ^a   Ferre, Sergi ^b   Franco, Rafael ^c   Canela, Enric ^a   McCormick, Peter J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DELTA OPIATE RECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; OLIGOMER; SIGMA 1 OPIATE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOPHYSICS; BRAIN NERVE CELL; CELL LEVEL; CHEMICAL ANALYSIS; COMPLEX FORMATION; CONTROLLED STUDY; CORPUS STRIATUM; CYTOLOGY; DOPAMINERGIC TRANSMISSION; DRUG SEEKING BEHAVIOR; INTRACELLULAR SIGNALING; MOLECULAR INTERACTION; MOLECULAR MECHANICS; MOUSE; NERVE CELL INHIBITION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION;

ANIMALS; CHO CELLS; COCAINE; COCAINE-RELATED DISORDERS; CORPUS STRIATUM; CRICETINAE; CRICETULUS; HEK293 CELLS; HUMANS; MALE; MICE; MICE, KNOCKOUT; PROTEIN MULTIMERIZATION; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, SIGMA;

ANIMALIA;

EID: 84876334881     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061245     Document Type: Article

References (63)

1. Kreitzer AC, Malenka RC, (2008) Striatal plasticity and basal ganglia circuit function. Neuron 60: 543-554 doi:10.1016/j.neuron.2008.11.005.
2. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, et al. (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250: 1429-1432.
3. Schiffmann SN, Vanderhaeghen JJ, (1993) Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons. J Neurosci 13: 1080-1087.
4. Kalivas PW, Volkow ND, (2005) The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162: 1403-1413 doi:10.1176/appi.ajp.162.8.1403.
5. Di Chiara G, Bassareo V, (2007) Reward system and addiction: what dopamine does and doesn't do. Current Opinion in Pharmacology 7: 69-76 doi:10.1016/j.coph.2006.11.003.
6. Durieux PF, Schiffmann SN, De Kerchove d'Exaerde A, (2012) Differential regulation of motor control and response to dopaminergic drugs by D1R and D2R neurons in distinct dorsal striatum subregions. EMBO J 31: 640-653 doi:10.1038/emboj.2011.400.
7. Xu M, Hu X-T, Cooper DC, Moratalla R, Graybiel AM, et al. (1994) Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell 79: 945-955 doi:16/0092-8674(94)90026-4.
8. Durieux PF, Bearzatto B, Guiducci S, Buch T, Waisman A, et al. (2009) D2R striatopallidal neurons inhibit both locomotor and drug reward processes. Nat Neurosci 12: 393-395 doi:10.1038/nn.2286.
9. Luo Z, Volkow ND, Heintz N, Pan Y, Du C, (2011) Acute Cocaine Induces Fast Activation of D1 Receptor and Progressive Deactivation of D2 Receptor Striatal Neurons: In Vivo Optical Microprobe [Ca2+]i Imaging. The Journal of Neuroscience 31: 13180-13190 doi:10.1523/JNEUROSCI.2369-11.2011.
10. Welter M, Vallone D, Samad TA, Meziane H, Usiello A, et al. (2007) Absence of dopamine D2 receptors unmasks an inhibitory control over the brain circuitries activated by cocaine. Proceedings of the National Academy of Sciences of the United States of America 104: 6840-6845.
11. Rougé-Pont F, Usiello A, Benoit-Marand M, Gonon F, Vincenzo Piazza P, et al. (2002) Changes in extracellular dopamine induced by morphine and cocaine: Crucial control by D2 receptors. Journal of Neuroscience 22: 3293-3301.
12. Krawczyk M, Sharma R, Mason X, DeBacker J, Jones AA, et al. (2011) A Switch in the Neuromodulatory Effects of Dopamine in the Oval Bed Nucleus of the Stria Terminalis Associated with Cocaine Self-Administration in Rats. The Journal of Neuroscience 31: 8928-8935 doi:10.1523/JNEUROSCI.0377-11.2011.
13. Thompson D, Martini L, Whistler JL, (2010) Altered ratio of D1 and D2 dopamine receptors in mouse striatum is associated with behavioral sensitization to cocaine. PLoS ONE 5: e11038 doi:10.1371/journal.pone.0011038.
14. De Mei C, Ramos M, Iitaka C, Borrelli E, (2009) Getting specialized: presynaptic and postsynaptic dopamine D2 receptors. Curr Opin Pharmacol 9: 53-58 doi:10.1016/j.coph.2008.12.002.
15. Beuming T, Kniazeff J, Bergmann ML, Shi L, Gracia L, et al. (2008) The binding sites for cocaine and dopamine in the dopamine transporter overlap. Nat Neurosci 11: 780-789 doi:10.1038/nn.2146.
16. Navarro G, Moreno E, Aymerich M, Marcellino D, McCormick PJ, et al. (2010) Direct involvement of sigma-1 receptors in the dopamine D1 receptor-mediated effects of cocaine. Proc Natl Acad Sci USA 107: 18676-18681 doi:10.1073/pnas.1008911107.
17. Canals M, Marcellino D, Fanelli F, Ciruela F, De Benedetti P, et al. (2003) Adenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization. Journal of Biological Chemistry 278: 46741-46749 doi:10.1074/jbc.M306451200.
18. González S, Moreno-Delgado D, Moreno E, Pérez-Capote K, Franco R, et al. (2012) Circadian-Related Heteromerization of Adrenergic and Dopamine D4 Receptors Modulates Melatonin Synthesis and Release in the Pineal Gland. PLoS Biol 10: e1001347 doi:10.1371/journal.pbio.1001347.
19. Carriba P, Navarro G, Ciruela F, Ferré S, Casadó V, et al. (2008) Detection of heteromerization of more than two proteins by sequential BRET-FRET. Nat Methods 5: 727-733 doi:10.1038/nmeth.1229.
20. Langa F, Codony X, Tovar V, Lavado A, Giménez E, et al. (2003) Generation and phenotypic analysis of sigma receptor type I (sigma 1) knockout mice. European Journal of Neuroscience 18: 2188-2196 doi:10.1046/j.1460-9568.2003.02950.x.
21. Moreno E, Hoffmann H, Gonzalez-Sepúlveda M, Navarro G, Casadó V, et al. (2011) Dopamine D1-histamine H3 receptor heteromers provide a selective link to MAPK signaling in GABAergic neurons of the direct striatal pathway. J Biol Chem 286: 5846-5854 doi:10.1074/jbc.M110.161489.
22. Moreno E, Vaz SH, Cai N-S, Ferrada C, Quiroz C, et al. (2011) Dopamine-Galanin Receptor Heteromers Modulate Cholinergic Neurotransmission in the Rat Ventral Hippocampus. J Neurosci 31: 7412-7423 doi:10.1523/JNEUROSCI.0191-11.2011.
23. Schroder R, Schmidt J, Blattermann S, Peters L, Janssen N, et al. (2011) Applying label-free dynamic mass redistribution technology to frame signaling of G protein-coupled receptors noninvasively in living cells. Nat Protocols 6: 1748-1760 doi:10.1038/nprot.2011.386.
24. Hayashi T, Su T, (2005) The sigma receptor: evolution of the concept in neuropsychopharmacology. Curr Neuropharmacol 3: 267-280.
25. Kourrich S, Su T-P, Fujimoto M, Bonci A, (2012) The sigma-1 receptor: roles in neuronal plasticity and disease. Trends Neurosci 35: 762-771 doi:10.1016/j.tins.2012.09.007.
26. Ng GYK, O'Dowd BF, Lee SP, Chung HT, Brann MR, et al. (1996) Dopamine D2 Receptor Dimers and Receptor-Blocking Peptides. Biochemical and Biophysical Research Communications 227: 200-204 doi:06/bbrc.1996.1489.
27. Lee SP, O'Dowd BF, Ng GYK, Varghese G, Akil H, et al. (2000) Inhibition of Cell Surface Expression by Mutant Receptors Demonstrates that D2 Dopamine Receptors Exist as Oligomers in the Cell. Molecular Pharmacology 58: 120-128.
28. Armstrong D, Strange PG, (2001) Dopamine D2 Receptor Dimer Formation. Journal of Biological Chemistry 276: 22621-22629 doi:10.1074/jbc.M006936200.
29. Guo W, Shi L, Javitch JA, (2003) The Fourth Transmembrane Segment Forms the Interface of the Dopamine D2 Receptor Homodimer. Journal of Biological Chemistry 278: 4385-4388 doi:10.1074/jbc.C200679200.
30. Guo W, Urizar E, Kralikova M, Mobarec JC, Shi L, et al. (2008) Dopamine D2 receptors form higher order oligomers at physiological expression levels. EMBO J 27: 2293-2304 doi:10.1038/emboj.2008.153.
31. Sharkey J, Glen KA, Wolfe S, Kuhar MJ, (1988) Cocaine binding at [sigma] receptors. European Journal of Pharmacology 149: 171-174 doi:16/0014-2999(88)90058-1.
32. Maurice T, Su T-P, (2009) The pharmacology of sigma-1 receptors. Pharmacol Ther 124: 195-206 doi:10.1016/j.pharmthera.2009.07.001.
33. Luttrell LM, Ferguson SS, Daaka Y, Miller WE, Maudsley S, et al. (1999) Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 283: 655-661.
34. Shenoy SK, Lefkowitz RJ, (2003) Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem J 375: 503-515 doi:10.1042/BJ20031076.
35. Beaulieu J-M, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, et al. (2005) An Akt/[beta]-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior. Cell 122: 261-273 doi:10.1016/j.cell.2005.05.012.
36. Shenoy SK, Drake MT, Nelson CD, Houtz DA, Xiao K, et al. (2006) beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J Biol Chem 281: 1261-1273.
37. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK, (2007) β-Arrestins and Cell Signaling. Annu Rev Physiol 69: 483-510 doi:10.1146/annurev.physiol.69.022405.154749.
38. Valjent E, Corvol J-C, Pages C, Besson M-J, Maldonado R, et al. (2000) Involvement of the Extracellular Signal-Regulated Kinase Cascade for Cocaine-Rewarding Properties. J Neurosci 20: 8701-8709.
39. Lu L, Koya E, Zhai H, Hope B, Shaham Y, (2006) Role of ERK in cocaine addiction. Trends in Neurosciences 29: 695-703 doi:10.1016/j.tins.2006.10.005.
40. Lobo MK, Covington HE, Chaudhury D, Friedman AK, Sun H, et al. (2010) Cell Type-Specific Loss of BDNF Signaling Mimics Optogenetic Control of Cocaine Reward. Science 330: 385-390 doi:10.1126/science.1188472.
41. Hoffmann HM, Nadal R, Vignes M, Ortiz J, (2012) Chronic cocaine self-administration modulates ERK1/2 and CREB responses to dopamine receptor agonists in striatal slices. Addict Biol 17: 565-575 doi:10.1111/j.1369-1600.2011.00353.x.
42. Callén L, Moreno E, Barroso-Chinea P, Moreno-Delgado D, Cortés A, et al. (2012) Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain. J Biol Chem 287: 20851-20865 doi:10.1074/jbc.M111.335273.
43. Pettit HO, Pan HT, Parsons LH, Justice JB Jr, (1990) Extracellular concentrations of cocaine and dopamine are enhanced during chronic cocaine administration. J Neurochem 55: 798-804.
44. Koob GF, (2006) The neurobiology of addiction: a neuroadaptational view relevant for diagnosis. Addiction 101Suppl 1: 23-30 doi:10.1111/j.1360-0443.2006.01586.x.
45. Di Chiara G, Bassareo V, (2007) Reward system and addiction: what dopamine does and doesn't do. Curr Opin Pharmacol 7: 69-76 doi:10.1016/j.coph.2006.11.003.
46. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ, (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237: 1219-1223.
47. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG, (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379: 606-612 doi:10.1038/379606a0.
48. Chen R, Tilley MR, Wei H, Zhou F, Zhou F-M, et al. (2006) Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter. Proc Natl Acad Sci USA 103: 9333-9338 doi:10.1073/pnas.0600905103.
49. Ferragud A, Velázquez-Sánchez C, Hernández-Rabaza V, Nácher A, Merino V, et al. (2009) A dopamine transport inhibitor with markedly low abuse liability suppresses cocaine self-administration in the rat. Psychopharmacology (Berl) 207: 281-289 doi:10.1007/s00213-009-1653-x.
50. Matsumoto RR, Liu Y, Lerner M, Howard EW, Brackett DJ, (2003) Sigma receptors: potential medications development target for anti-cocaine agents. Eur J Pharmacol 469: 1-12.
51. Cobos EJ, Entrena JM, Nieto FR, Cendán CM, Del Pozo E, (2008) Pharmacology and therapeutic potential of sigma(1) receptor ligands. Curr Neuropharmacol 6: 344-366 doi:10.2174/157015908787386113.
52. Kourrich S, Hayashi T, Chuang J-Y, Tsai S-Y, Su T-P, et al. (2013) Dynamic Interaction between Sigma-1 Receptor and Kv1.2 Shapes Neuronal and Behavioral Responses to Cocaine. Cell 152: 236-247 doi:10.1016/j.cell.2012.12.004.
53. Hiranita T, Soto PL, Tanda G, Katz JL, (2010) Reinforcing Effects of σ-Receptor Agonists in Rats Trained to Self-Administer Cocaine. Journal of Pharmacology and Experimental Therapeutics 332: 515-524 doi:10.1124/jpet.109.159236.
54. Hiranita T, Mereu M, Soto PL, Tanda G, Katz JL, (2013) Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists. Neuropsychopharmacology 38: 605-615 doi:10.1038/npp.2012.224.
55. Katz JL, Su T-P, Hiranita T, Hayashi T, Tanda G, et al. (2011) A Role for Sigma Receptors in Stimulant Self Administration and Addiction. Pharmaceuticals (Basel) 4: 880-914 doi:10.3390/ph4060880.
56. Matsumoto RR, McCracken KA, Friedman MJ, Pouw B, De Costa BR, et al. (2001) Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting sigma1 receptors produce anti-cocaine effects in mice. Eur J Pharmacol 419: 163-174.
57. Matsumoto RR, McCracken KA, Pouw B, Zhang Y, Bowen WD, (2002) Involvement of sigma receptors in the behavioral effects of cocaine: evidence from novel ligands and antisense oligodeoxynucleotides. Neuropharmacology 42: 1043-1055.
58. Hiranita T, Soto PL, Kohut SJ, Kopajtic T, Cao J, et al. (2011) Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors. J Pharmacol Exp Ther 339: 662-677 doi:10.1124/jpet.111.185025.
59. Alonso G, Phan V, Guillemain I, Saunier M, Legrand A, et al. (2000) Immunocytochemical localization of the sigma(1) receptor in the adult rat central nervous system. Neuroscience 97: 155-170.
60. Zhang D, Zhang L, Tang Y, Zhang Q, Lou D, et al. (2005) Repeated cocaine administration induces gene expression changes through the dopamine D1 receptors. Neuropsychopharmacology 30: 1443-1454 doi:10.1038/sj.npp.1300680.
61. Kim FJ, Kovalyshyn I, Burgman M, Neilan C, Chien C-C, et al. (2010) Sigma 1 receptor modulation of G-protein-coupled receptor signaling: potentiation of opioid transduction independent from receptor binding. Mol Pharmacol 77: 695-703 doi:10.1124/mol.109.057083.
62. Ferraro L, Frankowska M, Marcellino D, Zaniewska M, Beggiato S, et al. (2012) A novel mechanism of cocaine to enhance dopamine d2-like receptor mediated neurochemical and behavioral effects. An in vivo and in vitro study. Neuropsychopharmacology 37: 1856-1866 doi:10.1038/npp.2012.33.
63. Xu Y-T, Robson MJ, Szeszel-Fedorowicz W, Patel D, Rooney R, et al. (2012) CM156, a sigma receptor ligand, reverses cocaine-induced place conditioning and transcriptional responses in the brain. Pharmacol Biochem Behav 101: 174-180 doi:10.1016/j.pbb.2011.12.016.